Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study
Authors/Creators
- Vegezzi Elisa1
-
Cortese Andrea2
-
Bergsland Niels3
-
Mussinelli Roberta4
-
Paoletti Matteo5
-
Solazzo Francesca6
- Currò Riccardo7
- Ascagni Lucia8
- Callegari Ilaria9
- Quartesan Ilaria6
-
Lozza Alessandro10
- Deligianni Xeni9
-
Santini Francesco9
-
Marchioni Enrico5
- Cosentino Giuseppe1
- Alfonsi Enrico11
-
Tassorelli Cristina1
-
Bastianello Stefano1
-
Merlini Giampaolo4
-
Palladini Giovanni4
-
Obici Laura4
-
Pichiecchio Anna1
- 1. IRCCS Mondino Foundation, Pavia; University of Pavia (Italy)
- 2. UCL Queen Square Institute of Neurology; National Hospital Neurology Neurosurgery, London (UK); University of Pavia (Italy)
- 3. University at Buffalo, NY (USA); IRCCS Fondazione Don Gnocchi (Italy)
- 4. IRCCS Policlinico S. Matteo, Pavia; University of Pavia (Italy)
- 5. IRCCS Mondino Foundation, Pavia (Italy)
- 6. University of Pavia (Italy)
- 7. University of Pavia (Italy); UCL Queen Square Institute of Neurology; National Hospital Neurology Neurosurgery, London (UK)
- 8. Meyer Children's University Hospital, Florence (Italy)
- 9. University Hospital Basel (Switzerland)
- 10. IRCCS Policlinico S. Matteo; University of Pavia (Italy)
- 11. IRCCS Mondino Foundation, Pavia, (Italy)
Description
Background. The development of reproducible and sensitive outcome measures has been challenging in hereditary transthyretin (ATTRv) amyloidosis. Recently, quantification of intramuscular fat by magnetic resonance imaging (MRI) has proven as a sensitive marker in patients with other genetic neuropathies.
The aim of this study (title of the article: Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study) was to investigate the role of muscle quantitative MRI (qMRI) as an outcome measure in ATTRv.
Methods. Calf- and thigh-centered multi-echo T2-weighted spin-echo and gradient-echo sequences were obtained in patients with ATTRv amyloidosis with polyneuropathy (n=24) and healthy controls (n=12). Water T2 (wT2) and fat fraction (FF) were calculated. Neurological assessment was performed in all ATTRv subjects. Quantitative MRI parameters were correlated with clinical and neurophysiological measures of disease severity.
Results- Quantitative imaging revealed significantly higher FF in lower limb muscles in patients with ATTRv amyloidosis compared to controls. In addition, wT2 was significantly higher in ATTRv patients. There was prominent involvement of the posterior compartment of the thighs. Noticeably, FF and wT2 did not exhibit a length-dependent pattern in ATTRv patients. MRI biomarkers correlated with previously validated clinical outcome measures, Polyneuropathy Disability scoring system, Neuropathy Impairment Score (NIS) and NIS-lower limb, and neurophysiological parameters of axonal damage regardless of age, sex, treatment and TTR mutation.
Conclusions. Muscle qMRI revealed significant difference between ATTRv and healthy controls. MRI biomarkers showed high correlation with clinical and neurophysiological measures of disease severity making qMRI as a promising tool to be further investigated in longitudinal studies to assess its role at monitoring onset, progression, and therapy efficacy for future clinical trials on this treatable condition.
Notes
Files
Additional details
Related works
- Is published in
- Journal article: 10.1007/s00415-022-11336-z (DOI)